How AI will Reshape Life Science R&D | Guy Levy-Yurista, Chief Executive Officer at Synthace

Guy Levy-Yurista, CEO at Synthace joins the AI lab to share insight into the intersection of life sciences and new AI technology, and how it will revolutionize R&D for Big Pharma and beyond. Other topics include: Who should drive a company’s AI strategy? Guy's framework for evaluating & deploying new technology How Big Pharma is accelerating new drug development with AI How scientists can work smarter with AI-driven experiments An accomplished executive with deep multidisciplinary experience across science, technology and business, Guy specializes in commercializing advanced technologies in rapidly changing markets. Most recently, as CEO at Synthase, a life sciences R&D cloud company that is accelerating biological discovery by empowering scientists to flexibly program their lab automation without the need to code. He previously served as the Chief Strategy Officer for Sisense, where he played a pivotal role in their success as a market-leader for data analytics. Guy holds a PhD in Physics from the Weizmann Institute of Science in Israel, an MBA from The Wharton School at the University of Pennsylvania, and is a graduate of the Talpiot program at the Hebrew University of Jerusalem. → ⁠Connect with Guy → ⁠Learn more about Synthace